Endosomes, Lysosomes, and Autophagy

Core Explanation

The Endosomal Maturation Pathway

Endosomes are not a single compartment but a dynamic family of organelles that mature as they move inward from the plasma membrane:

Plasma Membrane → Early Endosome → Late Endosome / MVB → Lysosome
                         ↕
                  Recycling Endosome → Plasma Membrane

Early endosome (sorting endosome): The first destination for internalized cargo and membrane. Characterized by:

• pH ~6.0–6.5 (mildly acidic, driven by V-ATPase)
• Rab5 GTPase as the master identity marker — recruits PI3K (Vps34) to generate PI(3)P, which recruits EEA1 and other effectors
• Tubulovesicular morphology: the vacuolar body receives incoming vesicles; membrane tubules extend for recycling
• Sorting decisions: Receptors that release cargo at low pH (LDL receptor, asialoglycoprotein receptor) are sorted into recycling tubules. Cargo destined for degradation (activated EGFR, ubiquitinated proteins) is retained in the vacuolar portion

Recycling endosome: A tubular network enriched in Rab11. Cargo returns to the plasma membrane either directly from the early endosome (fast recycling, ~2–3 min, Rab4-dependent) or via the recycling endosome (slow recycling, ~10–20 min, Rab11-dependent). The recycling endosome is also a reservoir for plasma membrane components and SNAREs available for rapid redeployment.

Late endosome / multivesicular body (MVB): As the early endosome matures (Rab5 → Rab7 conversion), it develops intralumenal vesicles (ILVs). Key features:

• pH ~5.0–5.5
• Rab7 replaces Rab5 (Rab5 recruits the Mon1-Ccz1 complex, a Rab7 GEF, which drives the Rab5→Rab7 switch)
• PI(3)P is converted to PI(3,5)P₂ by PIKfyve
• Contains numerous 50–100 nm ILVs, giving the characteristic "multivesicular" appearance on EM
• ILVs are formed by the ESCRT machinery (see below)

The MVB has two fates: (1) fuse with the lysosome for degradation of its contents, or (2) fuse with the plasma membrane, releasing ILVs as exosomes (extracellular vesicles involved in intercellular communication).

ESCRT Machinery: Building ILVs

The ESCRT (Endosomal Sorting Complexes Required for Transport) pathway is responsible for sorting ubiquitinated membrane proteins into ILVs. Four multi-protein complexes act sequentially:

The ESCRT pathway is remarkable: it generates vesicles that bud away from the cytoplasm (into the endosome lumen) — the opposite topology of COPII/clathrin budding. ESCRT-III/Vps4 is also deployed for cytokinesis (abscission), HIV budding, and nuclear envelope resealing.

Lysosomes: The Terminal Degradative Compartment

Lysosomes are ~0.2–0.5 μm dense organelles containing ~60 acid hydrolases (proteases, lipases, nucleases, glycosidases). Key features:

• pH ~4.5–5.0 maintained by the V-ATPase, which pumps 2 H⁺ per ATP hydrolyzed
• LAMP1 and LAMP2 (lysosome-associated membrane proteins) are highly glycosylated on the lumenal side, forming a protective glycocalyx that resists degradation — the lysosome must not digest its own membrane
• Highly reduced lumen maintained by cystine transporter (cystinosin); mutations cause cystinosis
• Lysosomes also function as nutrient sensors: the mTORC1 kinase complex is recruited to the lysosomal surface by Rag GTPases when amino acids are abundant, promoting anabolic growth

Targeting hydrolases to lysosomes — the M6P pathway:

Lysosomal hydrolases are synthesized in the ER and modified in the cis-Golgi. The key sorting signal is mannose-6-phosphate (M6P):

1. GlcNAc-phosphotransferase in the cis-Golgi recognizes a "signal patch" (a 3D conformational motif) on lysosomal hydrolases and adds GlcNAc-P to mannose residues.
2. Uncovering enzyme (N-acetylglucosamine-1-phosphodiester α-N-acetylglucosaminidase) removes GlcNAc, exposing the M6P moiety.
3. M6P receptors (MPRs) in the TGN (cation-independent MPR, ~300 kDa, and cation-dependent MPR, ~46 kDa) bind M6P-tagged hydrolases.
4. MPR-hydrolase complexes are packaged into clathrin/AP1-coated vesicles at the TGN, destined for late endosomes.
5. Low pH in late endosomes dissociates the MPR-hydrolase complex; the MPR recycles back to the TGN via retromer.
6. The released hydrolase is proteolytically processed into its mature, active form in the lysosome.

I-cell disease (mucolipidosis II): Deficiency in GlcNAc-phosphotransferase → lysosomal enzymes lack M6P tag → secreted instead of delivered to lysosomes → lysosomes swell with undigested substrates (inclusion bodies) → severe skeletal abnormalities, developmental delay, death in early childhood.

Autophagy: Cellular Self-Eating

Autophagy ("self-eating") is a conserved catabolic process that delivers cytoplasmic material to lysosomes for degradation and recycling. Three types exist:

Macroautophagy (hereafter "autophagy") is the most extensively studied and clinically relevant. It proceeds through distinct stages:

The Autophagy Pathway

1. Initiation (Phagophore Formation):

• mTORC1 (mechanistic target of rapamycin complex 1) is the master negative regulator. Under nutrient-rich conditions, mTORC1 phosphorylates and inhibits the ULK1 complex (ULK1, ATG13, FIP200, ATG101).
• Under starvation (low amino acids, low ATP, low growth factors), mTORC1 is inactivated → ULK1 is dephosphorylated and activated.
• ULK1 phosphorylates components of the PI3K complex I (Beclin-1, Vps34, ATG14L, Vps15, NRBF2), activating Vps34 lipid kinase activity.
• Vps34 generates PI(3)P at the omegasome (a specialized ER subdomain), recruiting PI(3)P-binding proteins (WIPI2, DFCP1).

2. Phagophore Elongation — Two Ubiquitin-like Conjugation Systems:

• ATG12-ATG5-ATG16L1: ATG12 is conjugated to ATG5 (via ATG7, E1-like; ATG10, E2-like). The ATG12-ATG5 conjugate associates with ATG16L1 to form a large complex that localizes to the phagophore. This complex acts as a partial E3 ligase for the second system.
• LC3/ATG8 lipidation: LC3 (microtubule-associated protein 1A/1B-light chain 3) is cleaved by ATG4 to expose a C-terminal glycine (LC3-I). LC3-I is then conjugated to phosphatidylethanolamine (PE) via ATG7 (E1), ATG3 (E2), and the ATG12-ATG5-ATG16L1 complex (E3). Lipidated LC3 (LC3-II) embeds in the growing phagophore membrane and drives membrane expansion and closure.

LC3-II is the canonical autophagosome marker (puncta visible by fluorescence microscopy).

3. Cargo Recognition (Selective Autophagy): Selective autophagy receptors (p62/SQSTM1, NBR1, NDP52, OPTN) link cargo to LC3:

• Ubiquitin-dependent: Damaged mitochondria expose PINK1 on the outer membrane, recruiting Parkin (E3 ubiquitin ligase). Parkin ubiquitinates mitochondrial outer membrane proteins. p62 and OPTN bind both ubiquitin chains and LC3, tethering the mitochondrion to the growing autophagosome. This is mitophagy.
• Ubiquitin-independent: Some receptors (Bnip3, FUNDC1) directly bind LC3 without ubiquitin tags.

4. Autophagosome Closure and Maturation:

• The double membrane seals to form a complete autophagosome (~0.5–1.5 μm).
• ATG4 delipidates LC3-II from the outer membrane (recycling), while inner membrane LC3-II is degraded with the cargo.

5. Fusion with Lysosome:

• Autophagosomes traffic along microtubules (dynein-mediated) toward the perinuclear region where lysosomes concentrate.
• SNAREs (STX17 on autophagosome, SNAP29, VAMP8 on lysosome) mediate fusion, forming the autolysosome.
• Tethering: HOPS complex and Rab7 facilitate.
• Lysosomal hydrolases degrade the inner autophagosomal membrane and the sequestered cytoplasmic contents.
• Breakdown products (amino acids, fatty acids, sugars) are exported to the cytoplasm via lysosomal permeases for reuse.

Autophagy as a Stress Response

Starvation: Liver autophagy is dramatically upregulated within hours of fasting. Glycogen, lipid droplets, and proteins are degraded to supply amino acids and fatty acids for gluconeogenesis and ketogenesis. Mice with liver-specific ATG7 knockout die within 24 hours of birth (neonatal starvation).

Organelle quality control:

• Mitophagy: PINK1/Parkin pathway — mutations in PINK1 or PARK2 (Parkin) cause autosomal recessive early-onset Parkinson's disease, linking mitochondrial quality control failure to neurodegeneration.
• ER-phagy: ER turnover during stress.
• Pexophagy: Peroxisome degradation.
• Xenophagy: Selective autophagy of intracellular pathogens (bacteria, viruses).
• Aggrephagy: Clearance of protein aggregates (Huntington's, ALS-linked proteins).

Distinguishing Autophagy from Apoptosis

Important: Autophagy can be a double-edged sword. Moderate autophagy promotes survival during stress. Excessive autophagy, or autophagy in cells already committed to die, can contribute to "autophagic cell death" (type II programmed cell death). However, in most contexts, autophagy is fundamentally a pro-survival adaptation.

Energy and Directionality

• Endosome acidification: V-ATPase pumps 2 H⁺ per ATP hydrolyzed; maintaining a pH gradient of ~2.5 units (pH 7.2 → pH 4.8) requires continuous ATP expenditure
• ESCRT-III/Vps4: Vps4 AAA+ ATPase uses ATP to disassemble ESCRT-III polymers (~1 ATP per subunit released)
• Autophagy: ATP is required at multiple steps: ULK1 kinase phosphorylation, PI3K/Vps34 lipid kinase (converts ATP → PI(3)P), the ubiquitin-like conjugation systems (ATG7 uses ATP for ATG12 and LC3 activation), and lysosomal V-ATPase for autolysosomal degradation

Experimental Evidence

• I-cell disease discovery (Leroy & DeMars, 1967; Hickman & Neufeld, 1972): Fibroblasts from I-cell patients secreted lysosomal enzymes into the medium but had deficient intracellular enzyme activity. Co-culture of I-cell and normal fibroblasts corrected the defect (cross-correction), demonstrating that normal cells secrete a "corrective factor" (M6P-tagged enzymes) taken up by I-cell fibroblasts via M6P receptors. This elegantly proved the M6P sorting pathway.
• ESCRT discovery (yeast genetics, Emr lab, 2000s): Vps class E mutants accumulated aberrant endosomes (class E compartments) lacking ILVs, identifying ESCRT-0, I, II, III and Vps4.
• Autophagy genetics (Ohsumi, 1990s): Screened S. cerevisiae for autophagy-defective mutants; identified ATG (autophagy-related) genes. EM showed autophagic bodies accumulating in vacuoles of protease-deficient yeast under starvation. Nobel Prize 2016.
• LC3 as autophagosome marker (Kabeya et al., 2000): GFP-LC3 shows diffuse cytoplasmic fluorescence under fed conditions and bright puncta under starvation, enabling real-time monitoring of autophagy.
• PINK1/Parkin mitophagy (Narendra et al., 2008; 2010): Parkin is recruited to depolarized mitochondria; Parkin ubiquitinates outer membrane proteins; p62 links ubiquitinated mitochondria to LC3.

Disease and Clinical Relevance

Therapeutic insights:

• Enzyme replacement therapy (ERT): Recombinant M6P-tagged enzymes (imiglucerase for Gaucher, alglucosidase alfa for Pompe) are taken up via M6P receptors and delivered to lysosomes.
• mTOR inhibitors (rapamycin, everolimus): Induce autophagy by inhibiting mTORC1. Being explored for neurodegenerative diseases (clearing protein aggregates) and anti-aging.
• Chloroquine/hydroxychloroquine: Lysosomotropic agents that raise lysosomal pH, blocking autophagy at the degradation step. Used as autophagy inhibitors in cancer therapy clinical trials.

High-Yield Summary

1. Endosome maturation: Early endosome (Rab5, pH 6.0, sorting) → late endosome/MVB (Rab7, pH 5.0, ILVs via ESCRT) → lysosome (pH 4.5, degradation).
2. ESCRT pathway: 0→I→II→III→Vps4. Drives inward budding of ILVs. Also used for cytokinesis and viral budding.
3. M6P pathway: GlcNAc-phosphotransferase → M6P tag → MPR in TGN → clathrin/AP1 vesicle → late endosome → hydrolase release. I-cell disease = failure of this pathway.
4. Autophagy (macroautophagy): mTORC1 (nutrient sensor) → ULK1 → PI3K complex I → PI(3)P → ATG12/ATG5/ATG16 + LC3-PE (two ubiquitin-like systems) → autophagosome → lysosome fusion → degradation.
5. Selectivity: p62/SQSTM1 links ubiquitinated cargo (damaged mitochondria, protein aggregates) to LC3.
6. Autophagy vs. apoptosis: Autophagy = primarily survival (recycle to survive starvation); apoptosis = programmed death. Distinct molecular machinery.

Questions

Q1: During endosome maturation, the Rab5→Rab7 switch occurs. Propose an experiment using dominant-negative Rab mutants to test whether this switch is essential for endosomal maturation, and predict the result.

Q2: A child presents with developmental delay, coarse facial features, skeletal abnormalities, and recurrent infections. Enzyme assays show elevated lysosomal enzyme activity in serum but deficient activity in cultured fibroblasts. Name the disease, the molecular defect, and explain the paradoxical serum vs. cellular enzyme data.

Q3: A cancer cell line treated with a novel drug shows massive LC3-II accumulation on Western blot but no increase in autophagic degradation of long-lived proteins. Provide two mechanistic explanations for this apparent paradox, and describe an experiment to distinguish them.

Common Misconceptions

1. "Lysosomes are just waste bags." — FALSE. Lysosomes are dynamic signaling hubs: they sense amino acid availability via mTORC1, regulate cholesterol homeostasis, mediate plasma membrane repair, and even participate in antigen presentation (MHC class II).
2. "Autophagy and apoptosis are the same thing." — FALSE. Autophagy is primarily a survival mechanism that degrades cellular components for reuse. Apoptosis is programmed cell destruction. They use entirely different molecular machinery (ATG proteins vs. caspases). Chronic, excessive autophagy can contribute to cell death, but this is distinct from canonical apoptosis.
3. "All endosomes become lysosomes." — FALSE. Endosomes are dynamic: much of their membrane and many receptors recycle back to the plasma membrane. Only the vacuolar/MVB portion that retains ubiquitinated cargo is destined for lysosomal degradation.
4. "The M6P receptor is a plasma membrane receptor like the LDL receptor." — The M6P receptor (particularly CI-MPR) cycles between the TGN, endosomes, and the plasma membrane. At the plasma membrane, it can capture secreted lysosomal enzymes for re-internalization and delivery to lysosomes (the "secretory recapture" pathway), which is the basis for enzyme replacement therapy.
5. "Autophagy only happens during starvation." — FALSE. Basal autophagy occurs constitutively in all cells for quality control (mitochondrial turnover, aggregate clearance). Starvation dramatically upregulates it, but even well-fed cells use autophagy for organelle homeostasis. Liver-specific ATG7 knockout causes hepatomegaly and liver dysfunction within weeks, even with adequate nutrition.